- Home
- ITCI vs OSK Comparison
ITCI vs OSK Comparison
Compare ITCI & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- OSK
- Stock Information
- Founded
- ITCI 2002
- OSK 1917
- Country
- ITCI United States
- OSK United States
- Employees
- ITCI N/A
- OSK N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- OSK Auto Manufacturing
- Sector
- ITCI Health Care
- OSK Consumer Discretionary
- Exchange
- ITCI Nasdaq
- OSK Nasdaq
- Market Cap
- ITCI 8.0B
- OSK 7.3B
- IPO Year
- ITCI N/A
- OSK N/A
- Fundamental
- Price
- ITCI $86.00
- OSK $95.34
- Analyst Decision
- ITCI Strong Buy
- OSK Buy
- Analyst Count
- ITCI 12
- OSK 16
- Target Price
- ITCI $97.67
- OSK $124.50
- AVG Volume (30 Days)
- ITCI 455.4K
- OSK 644.1K
- Earning Date
- ITCI 02-20-2025
- OSK 01-28-2025
- Dividend Yield
- ITCI N/A
- OSK 1.93%
- EPS Growth
- ITCI N/A
- OSK 29.68
- EPS
- ITCI N/A
- OSK 10.30
- Revenue
- ITCI $613,728,000.00
- OSK $10,598,900,000.00
- Revenue This Year
- ITCI $48.41
- OSK $10.29
- Revenue Next Year
- ITCI $38.26
- OSK N/A
- P/E Ratio
- ITCI N/A
- OSK $9.25
- Revenue Growth
- ITCI 46.08
- OSK 12.82
- 52 Week Low
- ITCI $62.78
- OSK $93.34
- 52 Week High
- ITCI $93.45
- OSK $127.98
- Technical
- Relative Strength Index (RSI)
- ITCI 54.91
- OSK 31.25
- Support Level
- ITCI $82.76
- OSK $93.49
- Resistance Level
- ITCI $89.12
- OSK $101.52
- Average True Range (ATR)
- ITCI 2.48
- OSK 3.03
- MACD
- ITCI -0.04
- OSK -0.92
- Stochastic Oscillator
- ITCI 59.75
- OSK 9.27
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About OSK Oshkosh Corporation (Holding Company)Common Stock
Oshkosh is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms, a global leader. The company had manufactured joint light tactical vehicles for the us Department of Defense. However, Oshkosh recently lost the JLTV recompete, bringing into focus its us Postal Service contract, which calls for the electrification of us postal vehicles. The company reports in three segments—access equipment (52% of revenue), defense (22%), and vocational (27%)—and generated $9.6 billion in revenue in 2023.